A new family of quinoline and quinoxaline analogues of combretastatins

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 14, 2004, Pages 3771-3774

  Pérez Melero, Concepción ^a   Maya, Ana B S ^a   Del Rey, Benedicto ^a   Peláez, Rafael ^a   Caballero, Esther ^a   Medarde, Manuel ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Combretastatins; Quinolines; Tubulin polymerization inhibition

Indexed keywords

COMBRETASTATIN; QUINOLINE DERIVATIVE; QUINOXALINE DERIVATIVE;

ANIMAL CELL; ARTICLE; COLON ADENOCARCINOMA; CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LYMPHOMA CELL; MICROTUBULE ASSEMBLY; MODEL; NONHUMAN; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANTINEOPLASTIC AGENTS; BIOPOLYMERS; CELL LINE, TUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LIGANDS; NAPHTHALENES; QUINOLINES; QUINOXALINES; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; TUBULIN MODULATORS;

EID: 2942616949     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.04.098     Document Type: Article

References (17)

1. Hyams J., Lloyd C.W. Microtubules. 1994;Wiley-Liss, New York
2. Jordan A., Hadfield J.A., Lawrence N.J., McGown A.T. Med. Res. Rev. 18:1998;259
3. Pettit G.R., Cragg G.M., Herald D.L., Schmidt J.M., Lohavanijaya P. Can. J. Chem. 60:1982;1374
4. Pettit G.R., Singh S.B., Boyd M.R., Hamel E., Pettit R.K., Schmidt J.M., Hogan F. J. Med. Chem. 38:1995;1666
5. Dark G.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R., Chaplin D.J. Cancer Res. 57:1997;1829
6. Shi Q., Chen K., Morris-Natschke S.L., Lee K.H. Curr. Pharm. Des. 4:1998;219
7. Pettit G.R., Temple C. Jr., Narayanan V.L., Varma R., Simpson M.J., Boyd M.R., Rener G.A., Bansal N. Anticancer Drug Des. 10:1995;299
8. Nandy P., Banerjee S., Gao H., Hui M.B., Lien E. J. Pharm. Res. 8:1991;776
9. Brown M.L., Rieger J.M., Macdonald T.L. Bioorg. Med. Chem. 8:2000;1433. and references cited therein
10. Maya A.B.S., del Rey B., Peláez Lamamié de Clairac R., Caballero E., Barasoain I., Andreu J.M., Medarde M. Bioorg. Med. Chem. Lett. 10:2000;2549
11. Maya, A. B. S.; Pérez-Melero, C.; Mateo, C.; Alonso, D.; Fernández, J. L.; Peláez, R.; Caballero, E.; Medarde, M. J. Med. Chem., in press
12. Plobek N., Delorme D., Wei Z.-Y., Yang H., Zhou F., Schwarz P., Gawell L., Gagnon H., et al. J. Med. Chem. 43:2000;3878
13. Deady L.W., Desneves J., Ross A.C. Tetrahedron. 49:1993;9823
14. For the determination of aqueous solubility, samples were shaken in 10 mM phosphate buffer, pH 7.0, at room temperature for 72 h. Next, they were filtered and their absorbance in the UV-vis was measured. Solubility: mg/mL is 1a: 0.04, 3a: 0.07, 4a: 0.03, 5a: 0.04, 7a: 0.01, naphthylcombretastatin: 0.01 and CS A-4: 0.05. (The value reported in the literature for CS A-4 is 0.11 mg/mL in PBS; Ohsumi K., Hatanaka T., Nakagawa R., Fukuda Y., Morinaga Y., Suga Y., Nihei Y., Ohishi K., Akiyama Y., Tsuji T. Anticancer Drug Des. 14:1999;539. )
15. San Feliciano A., Medarde M., Peláez Lamamié de Clairac R., López J.L., Puebla P., Grávalos M.D.G., Ruiz P., García de Quesada M.T. Arch. Pharm. (Weinheim). 326:1993;421
16. Dumortier C., Gorbunoff M., Andreu J.M., Engelborghs Y. Biochemistry. 35:1996;4378-4395
17. Ohsumi K., Nakagawa R., Fukuda Y., Hatanaka T., Morinaga Y., Nihei Y., Ohishi K., Suga Y., Akiyama Y., Tsuji T. J. Med. Chem. 41:1998;3022